We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $4.05B
1-Year Est. Return 19.01%
This Fund
S&P 500
This Quarter Est. Return
+5.05%
1 Year Est. Return
+19.01%
3 Year Est. Return
+47.13%
5 Year Est. Return
+48.95%
10 Year Est. Return
+147.53%
AUM
$1.17B
AUM Growth
+$69.9M
Cap. Flow
-$123M
Cap. Flow %
-10.45%
Top 10 Hldgs %
45.17%
Holding
233
New
50
Increased
46
Reduced
102
Closed
21

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$30.7M
2
VIG icon
Vanguard Dividend Appreciation ETF
VIG
+$27.7M
3
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$19.3M
4
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$19.1M
5
BND icon
Vanguard Total Bond Market
BND
+$13.3M

Top Sells

Rank Stock Value
1
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$124M
2
MUB icon
iShares National Muni Bond ETF
MUB
+$108M
3
EEMV icon
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
+$27.6M
4
QEMM icon
State Street SPDR MSCI Emerging Markets StrategicFactors ETF
QEMM
+$5.28M
5
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$5.01M

Sector Composition

Rank Sector Weight
1 Financials 4.56%
2 Technology 3.54%
3 Communication Services 2.54%
4 Healthcare 2.13%
5 Industrials 1.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRM icon
201
Salesforce
CRM
$142B
$206K 0.02%
+2,499
New +$200K
GILD icon
202
Gilead Sciences
GILD
$165B
$201K 0.02%
+2,944
New +$207K
GS icon
203
Goldman Sachs
GS
$311B
$200K 0.02%
+870
New +$210K
FLL icon
204
Full House Resorts
FLL
$87.4M
$189K 0.02%
77,600
– –
CHGG icon
205
Chegg
CHGG
$97.7M
$169K 0.01%
+20,000
New +$154K
HBAN icon
206
Huntington Bancshares
HBAN
$36.6B
$153K 0.01%
11,425
– –
AMLP icon
207
Alerian MLP ETF
AMLP
$12.8B
$143K 0.01%
+2,255
New +$145K
IAU icon
208
iShares Gold Trust
IAU
$62.2B
$122K 0.01%
5,049
-7,651
-60% -$180K
GMZ
209
DELISTED
Goldman Sachs MLP Income Opportunities Fund
GMZ
$113K 0.01%
+1,513
New +$114K
UBFO
210
DELISTED
United Security Bancshares
UBFO
$90K 0.01%
+12,481
New +$95.5K
ZIXI
211
DELISTED
Zix Corporation
ZIXI
$77K 0.01%
+16,000
New +$79K
IMI
212
DELISTED
Intermolecular, Inc.
IMI
$63K 0.01%
+67,246
New +$70.2K
AMT icon
213
American Tower
AMT
$77.8B
– –
-3,076
Closed -$325K
BBH icon
214
VanEck Biotech ETF
BBH
$394M
– –
-23,280
Closed -$2.5M
BLK icon
215
Blackrock
BLK
$163B
– –
-850
Closed -$323K
BMRC icon
216
Bank of Marin Bancorp
BMRC
$463M
– –
-9,066
Closed -$316K
DD icon
217
DuPont de Nemours
DD
$18.3B
– –
-2,055
Closed -$298K
DINO icon
218
HF Sinclair
DINO
$16.3B
– –
-18,605
Closed -$610K
GSG icon
219
iShares S&P GSCI Commodity-Indexed Trust
GSG
$985M
– –
-10,240
Closed -$160K
HYD icon
220
VanEck High Yield Muni ETF
HYD
$4.5B
– –
-8,932
Closed -$530K
MCK icon
221
McKesson
MCK
$97.3B
– –
-2,317
Closed -$325K
MTG icon
222
MGIC Investment
MTG
$6.2B
– –
-11,000
Closed -$112K
QAI icon
223
NYLI Hedge Multi-Strategy Tracker ETF
QAI
$1B
– –
-50,136
Closed -$1.44M
RSPH icon
224
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$738M
– –
-13,990
Closed -$204K
TGT icon
225
Target
TGT
$63.4B
– –
-13,136
Closed -$949K
6 7 8
9
10

Similar funds

ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
MR
Munich Reinsurance Munich $4.07B AUM
CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
MGP
Metis Global Partners San Diego, California $4.07B AUM 30.82% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return

Aspiriant LLC's Q1 2017 Portfolio in Review

As of Q1 2017, Aspiriant LLC held 233 positions worth $1.17B, up 6.3% from $1.1B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Aspiriant LLC withdrew a net $123M in Q1 2017, closing 21 positions and reducing 102 holdings. Its most notable exit was VanEck Biotech ETF, an estimated $2.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 4.6% of assets, down from 5.1% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Aspiriant LLC opened a new position in Vanguard Short-Term Corporate Bond ETF worth $19.1M.

  • Aspiriant LLC's largest Q1 2017 buy was Vanguard Short-Term Corporate Bond ETF: 240,133 shares worth $19.1M.
  • Aspiriant LLC added most to Vanguard S&P 500 ETF in Q1 2017, an estimated $30.7M increase.
  • Aspiriant LLC's biggest Q1 2017 reduction was Berkshire Hathaway Class A, cutting an estimated $124M.
  • Aspiriant LLC fully exited VanEck Biotech ETF in Q1 2017, selling an estimated $2.5M.
  • Aspiriant LLC's ten largest holdings make up 45% of its $1.17B portfolio in Q1 2017.
  • Aspiriant LLC opened 50 new positions and closed 21 in Q1 2017.
  • Aspiriant LLC's portfolio value rose 6.3% quarter-over-quarter to $1.17B.

Based on Aspiriant LLC's 13F filing for Q1 2017, filed 15 May 2017.